Accentuate the Positive: Eva Moon at the Joining FORCEs Conference

More than 700 individuals facing hereditary breast and ovarian cancer gathered at the Philadelphia Marriott for the 2014 Joining FORCEs Conference held by Facing Our Risk of Cancer Empowered in partnership with Penn Medicine’s Basser Research Center for BRCA.

As the Philadelphia Inquirer reports, performer Eva Moon spoke at the 2014 joining FORCEs Conference last month, integrating humor with the otherwise serious topic of hereditary cancer.

Hereditary breast and ovarian cancer is often caused by mutations in the BRCA1 and BRCA2 genes, which increase risk for breast, ovarian and other cancers.

Moon, who carries a BRCA1 mutation, uses humor as a method to cope with tough times. She performs a one-woman musical about her journey with hereditary breast and ovarian cancer.

At the conference, Moon shared her personal story, tips for finding humor in daily life, and engaged the audience with a number of songs and activities.

"I cried rivers of tears," she said. But she fought back and underwent a series of major preventative surgeries. Post-recovery, Moon harnesses humor for coping with hard times, and she is teaching others to do the same.

"Humor can relieve stress and speed healing," she said.

Read the Philadelphia Inquirer coverage of Eva Moon's session online.

Read More

Artist and Survivor Jacob Riley-Wasserman Inspires Flip4Cancer.com to Benefit Abramson Cancer Center

Jacob Riley-Wasserman has an eye for the interesting and unusual.

After completing his studies in furniture design at the Rhode Island School of Design, Jacob planned to start a graduate program at New York University when he began having difficulty swallowing. He was only 22.

“I had an endoscopy at Penn Medicine that summer, and went back to New York to begin to prepare for grad school,” Jacob remembers. “It was just before I was to start school again that I learned I had esophageal cancer.”

Jacob returned to his home in New Jersey to receive proton therapy and chemotherapy at Penn Medicine.

It was at the Roberts Proton Therapy Center where Jacob became fascinated by the treatment process. “I was amazed that this beam of proton radiation was hitting my tumor without radiating to other areas of my body,” says Jacob.

As a designer and artist, Jacob was especially drawn to the compensator blocks used to direct the proton beam to the treatment area.

“Compensator blocks are custom made to fit the patient and their particular tumor,” says Jim Metz, MD, vice chair of radiation oncology at Penn. “Before proton therapy begins, the blocks are created based on scans of the patient’s anatomy and tumor site. Each time they come in for therapy, the compensator blocks are placed in the beam line to shape the distribution of protons over the target area while sparing exposure to normal tissue.”

Jacob was so fascinated with the compensator block, he asked to take his home. Then, he had another idea.

“I thought it would be a cool thing to start offering to patients,” says Jacob. “So we are beginning a program in which patients take their blocks home after a small donation is made to patient education at the Abramson Cancer Center.”

Today, Jacob’s tumor in his esophagus is gone, but he is still undergoing treatment at the Abramson Cancer Center.

While on leave from school, he is staying busy in his workshop.

His most successful design is the Star Spangled Spatula. Crafted of solid walnut and stainless steel, the over-sized grilling spatula has been highlighted in national publications like the New York Times, Martha Stewart Living, and Fast Company. Jacob licensed it with New York based firm, Areaware, and it has been sold across the country in home stores including Williams Sonoma, Bed, Bath & Beyond, and shops in some of the nation’s prominent museums. There’s also a smaller vinyl version for kitchen use.

With the spatula’s popularity, Jacob has decided to donate a portion of the percentage he receives from its sale to the Abramson Cancer Center.

“My cancer diagnosis has been a huge blow but I’ve been trying to keep as busy as possible,” he says. “I like to be working and make stuff. I work with my hands. This has been my opportunity to be on top of that. I don’t just have cancer, get treatment, and sit at home. I’ve been using this as an opportunity to create -  the perspective on that is interesting.”

To purchase a Star Spangled Spatula, or to learn more about Jacob, visit www.flip4cancer.com

Read More

Join the Peter Skelton Sarcoma Research Foundation's Annual Walk/Run/Cycle This Weekend!

Join friends and family of the Peter Skelton Sarcoma Research Foundation to raise funds and awareness of sarcoma.

Partial proceeds benefit the sarcoma programs at the Abramson Cancer Center at Pennsylvania Hospital.

Peter Skelton was a young man in his prime. He had a contagious laugh and a zest for life. On July 9, 2003, at the age of 36, doctors found a tumor. He had surgery in August, was diagnosed with soft tissue sarcoma, and was admitted to Johns Hopkins in late September. He passed away on November 2.

Pete’s valiant battle, from diagnosis to death, lasted a little less than four months. That was a very short time – four months – to comprehend that he had a malignant cancer, find a specialist for this relatively unknown disease, and just simply hope that some treatment existed to help.

The Peter Skelton Sarcoma Research Foundation was founded by Pete’s brother and sisters in memory of Peter. Their wish, as his would be, is to help others fight sarcoma cancer.

Peter Skelton Sarcoma Research Foundation Annual Sarcoma Walk/Run/Cycle

Date: Sunday, July 13, 2014, 7:30 – 11:30am
Location: RiverWinds in West Deptford, New Jersey
Times: Cycle: 7:30 am, Walk: 8:30 am, Run: 9 am

Benefits the Abramson Cancer Center's Joan Karnell Supportive Care Program at Pennsylvania Hospital

Register here, or contact Marylou  at 215-829-6466 or Carly 215-829-6737 for more information.

Read More

Cancer-free, and on the Road - Jim Finkel's Survival Story

Jim Finkel was never one to shy away from a challenge.

As a competitive cyclist in the 70s, he rode alongside some of the best cyclists in the world. Jim didn’t know it at the time, but his constant challenges to go faster, work harder, go longer distances, and fuel his body with proper nutrition got him in shape for the greatest challenge of his life – cancer.

“Towards the end of 2012 I was having trouble breathing, either on or off the bike,” says the 61-year-old mechanical engineer. “I was unable to clear my nostrils on the road, and when over-the-counter medications and antibiotics didn’t work, we knew it was time to take the next step toward a proper diagnosis.”

After scopes and scans revealed a tumor in his nasal cavity, Jim’s ear/nose/throat specialist in Delaware performed surgery. The hospital was not able to easily identify the tumor so the tissue samples were sent to the Mayo Clinic. The malignant tumor type was rare, as was the location of the tumor. Typing is important in deciding the treatment course and this tumor was resistant to chemotherapy.

Knowing the type of tumor, and the precision needed to make sure all "margins" were clear, Jim was referred to Penn Medicine’s Abramson Cancer Center by his own doctor, and father in law, who happened to be a retired physician.

“They assured me Dr. Bert O’Malley was the best out there, and the one who could take care of what needed to be done,” says Jim. “Because the tumor was rare, my case made it to the tumor board. This is not an honor you want!”

Jim needed more surgery to be sure the tumor had not spread, and radiation therapy was planned for after. But before his second surgery, he had some time to heal… and get back on the bike.

“My breathing was immediately better following the first surgery and I could not wait to get back on the bike,” he remembers. “While I was permitted to ride, I was told to ‘take it easy,’ which I did, sort of. I kept my maximum pulse to 90% and I turned down the watt rating also to 90%.”

“When it was warm enough to ride outside, I started to kick up my mileage, without pushing it. By the time the second surgery was to take place, I got in a nice 31-mile ride on Sunday, in advance of the Tuesday surgery,” Jim remembers. “The day after the surgery, Dr. O’Malley walked in, looked at me, and said, ‘You look great!’”

Jim’s second surgery was called “clean-up” and was intended to clear out any tissue that was seen as “PET active.” All of the tissue samples came back clean, so he was breathing easier on all fronts once again.

For six weeks after surgery, Jim received radiation therapy at Penn Medicine Valley Forge.

“The treatments were relatively smooth sailing, and the staff was great,” says Jim. “I am nearly bald, but I was told that I might suffer some hair loss, and my only question was ‘How would I know?’”

“Even though I’d started radiation therapy, I was back up to doing at least four hours a week of saddle time on a bike,” says Jim. “Keeping my weight up during treatment was a challenge, but cycling actually helped. Though my sense of taste was dulled, I was used to getting calories back into my body. I knew I had to eat and carefully match my calories taken in to my calories burned. I managed to hold weight throughout the process - eating a lot of Indian food!” Jim jokes.

Now, nearly two years after his journey with cancer started, Jim remains cancer-free and is still cycling like a champ.

In fact, he is joining the Abramson Cancer Center’s Ride to Conquer Cancer, a 2-day, nearly 150 mile bike ride that benefits cancer research at the Abramson Cancer Center.

“I can’t say enough about the Abramson Cancer Center,” says Jim. “My surgeon Dr. O’Malley, my oncologist, Dr. Chip Staddon at Penn Medicine at Radnor, and Dr. Geoffrey Geiger at both the Valley Forge and the Perelman Center for Advanced Medicine always put me as a person in front of me as a patient. Plus the staff at all locations have been phenomenal.”

Jim adds, “I want my story to give others hope.”

Learn more about, or join the Ride to Conquer Cancer here. 

Read More

Penn's Basser Research Center for BRCA Presents at ASCO 2014

Early this summer, oncologists from around the world gathered to hear cutting-edge scientific presentations showcasing new findings in oncology at the American Society of Clinical Oncology. Investigators from Penn Medicine’s Basser Research Center for BRCA presented on a range of topics related to hereditary breast and ovarian cancer. 

Multiplex Testing

Katherine L. Nathanson, MD, presented on 'multiplex testing" for hereditary cancer risk. Historically, individuals with family histories of cancer were told about the individual genes that may be at the root the family’s history of cancer.

For example, a 40-year-old woman with breast cancer whose paternal grandmother also had the disease might be advised to consider BRCA1 and BRCA2 testing. Similarly, a 25-year-old woman with breast cancer might be offered testing for BRCA1 and BRCA2 but also a gene called TP53 associated with much younger breast cancers.

Now, in 2014, multiplex or “panel” testing allows a healthcare provider to offer individuals testing for genes which have a predisposition to cancer all at once. This commercially available test has brought opportunities and challenges to the world of cancer genetics for patients and providers alike. ASCO 2014 highlighted the divergent opinions on the new technology.

To learn more:

• Watch Kate Nathanson, MD, discuss her gene panel abstract in an interview with MedPageToday.
• Read coverage in an article on HemOnc Today
• Listen to Basser staff Susan Domchek, MD, Kara Maxwell, MD, PhD, and Katherine Nathanson, MD, on WHYY Radio

Breast Cancer Worry in Teens

Families with BRCA mutations or unrelated histories of breast cancer often wonder how this history can impact their girls as they grow into young adults.

Basser Investigator, Angela Bradbury, MD, has devoted her career to studying these issues and discusses her abstract on worry and behavior among teens at higher risk for breast cancer.

To learn more:

• Angela Bradbury, MD, speaks with WHYY Radio 
• Read the Penn Medicine press release
• Angela Bradbury, MD, comments on incidental findings from genetic testing here

Side Effects of Risk-Reducing Salpingo Oophorectomy

For women who carry BRCA mutations, in is standard practice to discuss preventative removal of the ovaries and fallopian tubes between ages 35 to 40 or after child-bearing is complete.

These discussions inevitably lead to concerns about the potential impact of the procedure, which is called risk-reducing salpingo oophorectomy.

To learn more about Susan Domchek MD's research, you can read her interview with MedPage Today or see the Penn Medicine News Release.

For hereditary breast and ovarian cancer information, support, and research opportunities, visit Basser.org

Read More

Melanoma, Lymphoma and The Three Young Reasons I Support Cancer Research

Rob is riding in this fall's Philadelphia Ride to Conquer Cancer®, a 2-day, 150*-mile bike ride that benefits the Abramson Cancer Center. In 2006, Rob's wife, Edith, lost her battle with cancer leaving behind three young children. Just months later, Rob was diagnosed with melanoma. In this blog, he shares his story.

In 2005, I had it all – a beautiful wife, a high profile job on Wall Street, a wonderful home in the Philadelphia suburbs, and three adorable children. But our lives were about to dramatically change.

It was New Year’s Eve, and my wife complained of shortness of breath and started vomiting. At the emergency room, a scan revealed a large mass in her chest cutting off her main artery and crowding her lungs and stomach. Three days later she was diagnosed with PMBL lymphoma – a form of cancer that strikes women of child-bearing age. Six short months later, she had failed all therapies and we were in a desperate fight to delay the inevitable. When she died in early October, she left behind three small children – ages 4, 6 and 7 – and a huge hole in our lives.

Two months after her death I was diagnosed with stage 3 melanoma – a mole on my back that had been neglected while I cared for my wife. I remember telling my dermatologist “I can’t have cancer. My wife just died and I have three small children to care for.”

The standard of surgical care for the mole on my back involved removing an area the size of a salad plate. I returned to work two days later pretending that nothing had happened. Miraculously, I was able to keep up with my high stress job while holding things together as a single parent.

However, melanoma is terribly tenacious. In less than two years it was back. This time in my lymph system and the odds were not in my favor.

I must admit that I hesitated to get treatment. There was a high probability the surgery, which would remove 22 lymph nodes from my groin and left leg, would lead to lymphedema – a progressive, degenerative swelling of my leg. I had led a very active life and I had no desire to spend the rest of it disabled. I delayed the decision for almost two months. In the end, I decided to have both the surgery and follow-up chemotherapy in the hope of remaining healthy enough to care for my children. Post-surgery, the physical therapist told me it was unlikely that I would be able to ride a bike again. Cycling was my passion.

But here I am. I received my treatment at the Abramson Cancer Center under the supervision of Dr. Lynn Schuchter. Thankfully, due to their excellent care, I am NED (no evidence of disease). In an effort to help fight this disease, I have signed up for the Ride to Conquer Cancer, and am a member of Team Mission Melanoma. We plan to ride 150 miles this October 11 and 12 to help support cancer research at Abramson Cancer Center. Won’t you join us in supporting the fight against cancer?

Sign up to ride with us, or, make a donation to my team here.

My family and I thank you. Together we can find a cure.

The Ride to Conquer Cancer

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Philadelphia Ride to Conquer Cancer (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque landscape -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two-days and 150+ miles, the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to ride side by side with physicians, patients and families --raising serious funds and awareness in the ACC’s fight to cure cancer.

Before the ride, you will have access to:

• Expert coaching
• Training rides in your area
• Personal web page for fundraising
• Helpful manual
• 2014 ride commemorative item

During the ride, participants will have access to:

• Event-day ride jersey
• Support along the route
• Catered meals
• Entertainment at camp
• Massage and medical care

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

Join Today

This event will be remarkable, bringing together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

*actual route distance may vary by up to 30 miles.

Read More

Penn's Amyloidosis Program Attend International Symposium and Report on Clinical Trials

Recently, several hundred investigators from around the globe gathered in Indianapolis, IN for the fourteenth International Symposium on Amyloidosis, April 27-May 1, 2014 to discuss the rare disease, recent findings, and ongoing clinical trials. Members of Penn Medicine's multidisciplinary Amyloidosis Program were in attendance and provide commentary on some highlights from the meeting.

Amyloidosis: A brief summary

Amyloidosis is a group of diseases characterized by the buildup of abnormal proteins called "amyloid fibrils" in tissues and organs throughout the body. Over time, this accumulation alters the ability for organs to function normally and leads to health complications. Left untreated, amyloidosis can be potentially life threatening, so receiving an early, accurate diagnosis is very important.

Diagnosing amyloidosis is not easy, however. Symptoms can be vague and are often similar to those of other diseases. In addition, symptoms can appear in several organs at the same time, spanning the areas of cardiology, nephrology and neurology, for example.

Often, the presence of many persistent, unrelated symptoms is what alerts a physician to the possibility of amyloidosis.

Penn Medicine's Contribution: Evolving Therapies 

The Amyloidosis Program at Penn Medicine is involved in the treatment and diagnosis of amyloidosis and the development of new drugs to treat the disease and its variants. Amyloidosis can have a variety of causes, and as a result, the Program brings together specialists from cardiology, nephrology, hematology-oncology, neurology, rheumatology, pulmonology and organ transplantation.

The following information is derived from presentations made at the fourteenth ISA, by members of the Penn Amyloidosis Program:

NEOD001 - A New Approach to Treating Cardiac Amyloidosis by Targeting Existing Organ Deposits

The Penn Amyloidosis Program is involved in the development of a promising new drug called NEOD001, which is designed to target and remove the buildup of amyloids in the heart and other affected organs. So far, the majority of patients in the study have seen stability or improvement in the blood tests that measure the impact of amyloidosis on the heart.

The primary investigator for the NEOD001 study at Penn Medicine, Brendan Weiss, MD, director of the Penn Amyloidosis Program, is enthusiastic about the preliminary results.

“The capacity to target existing amyloid fibrils in the tissues is among the great unmet needs of amyloidosis therapy,” Dr. Weiss says. “The safety information from this trial is reassuring, and while the organ response data are very preliminary, they are encouraging, and suggest further development of this approach is needed.”

Penn Researcher Investigating Kiacta™ for Treating AA Amyloidosis in International Study

A team of researchers, including Laura M. Dember, MD, of the Renal Electrolyte and Hypertension division at Penn Medicine, presented findings from an ongoing clinical trial of Kiacta™, an oral drug for the treatment of AA amyloidosis. A variant of the disease, AA amyloidosis is associated with kidney failure. This clinical trial looks to confirm findings from earlier trials around safety and effectiveness of Kiacta. 

Further Research Presented at the 14th ISA

In other developments at the fourteenth ISA, Adam Cohen, MD of the Amyloidosis Program at Penn commented on a study presented by Vaishali Sanchorawala from the Amyloidosis Center at Boston University. Dr. Sanchorawala’s study involves the use of drugs melphalan and bortezomib before and after stem cell transplant to treat patients with primary systemic amyloidosis.

Dr. Cohen observes that while the Boston University study confirms the activity of bortezomib in AL amyloidosis and its potential to further improve outcomes in patients undergoing autologous stem cell transplant, 14% of participants were unable to proceed to transplant, due to clinical deterioration during induction therapy.

“This suggests that going directly to transplant for transplant-eligible patients and reserving the bortezomib/dexamethasone until post-transplant may be a preferred approach,” Dr Cohen says, noting that further validation of these approaches in larger prospective trials is warranted.

For additional information on the program, including consultations, scheduling, and resources from Penn Medicine’s Amyloidosis Program, please contact the program by email, or call 800-789-PENN (7366).

Read More

Megan's Story: From Sarcoma to Survivor

"When I came to the Abramson Cancer Center (ACC) with stage 2 synovial sarcoma, I needed hope and I needed help. Dr. Kristy Weber treated my cancer in a way no one else could. She saved my leg and my life. Thanks to the sarcoma program at the ACC, I am a three-month cancer survivor.”  Megan Dychala, sarcoma cancer survivor

At 23, Megan Dychala was a former college soccer player who thought her nagging knee pain was a result of old injuries. She was young, active, and enjoying all that life had to offer her. But, in October, 2013 she got a phone call that would change her life.

Megan’s ongoing knee pain was in fact a tumor behind her knee. One day she was healthy and the next she was faced with a rare and aggressive cancer. Although statistics were against Megan, she knew she wouldn't let anything happen without a fight.

Luckily Megan found Penn’s Abramson Cancer Center and Kristy Weber, MD. While other hospitals said that amputation was her only chance for survival, Dr. Weber knew she could do better – treating Megan’s cancer, but also ensuring a good quality of life after treatment.

Megan shares her personal journey at the Abramson Cancer Center below.

 

My Sarcoma Story

My medical team worked with me to develop an aggressive treatment plan that included five and a half weeks of daily radiation followed by an intense surgery. Dr. Stephen Hahn was my rockstar of a radiation oncologist and took care of me every step of the way. Radiation left me burned and uncomfortable, but it is truly amazing how the skin recovers from so much trauma.

 

My leg after 3, 4, and 5.5 weeks of radiation treatment.

Finishing radiation and ringing the bell, surrounded by my family and the other cancer warriors there, was one of the best days of my life.

The surgery we opted for allowed me to keep my leg, but I would be sacrificing abilities. With so much reconstruction and working with nerves, there is no guarantee the leg will regain proper function. I was told I could never walk without a cane or walker and that I could need to wear a leg brace, possibly for the rest of my life, to support my foot. I was also told I could have limited mobility restricting things like driving and basic daily tasks.

The "what could bes" were daunting, but I trusted Dr. Weber and my vascular and plastic surgeon guru Dr. Stephen Kovach. Together, Drs. Weber and Kovach removed the back of my knee and rebuilt my leg through vascular, skin, and muscle grafts in a 14-hour surgery. I had a long road ahead of me, and a mountain of unknowns to climb.

Drs. Weber and Kovach's work was phenomenal. Less than six weeks after surgery, I was walking on my own two feet. I never had to use a cane or walker. I don't wear a leg brace. I drive my car, work out at the gym, and walk my dog. My leg function is improving everyday, and I see a 100 percent return in my future. This experience has taught me a lot, but most importantly, no matter how much the deck is stacked against you, or how grim the statistics look, you should always remember that you can be the one to improve the statistics.

A positive attitude goes an incredibly long way. I was diagnosed with a “one in a million cancer,” but now I am one more survivor. I owe this second chance at life to my amazing team at Penn Medicine and the Abramson Cancer Center.

Less than 4 months after diagnosis, I was celebrating being cancer free.

Read More

Men's Health Monday: Colorectal Cancer

Approximately 90 percent of colorectal cancers are thought to be preventable. Other than skin cancers, colorectal cancer is the third most common cancer diagnosis among men and women in the United States. Studies show that 1 in 20 Americans develop colorectal cancer during their lifetime.

What is Colon Cancer?

Colon cancer is the development of malignant tumors inan in the lining tissue of the colon. Most colon tumors begin when normal tissue forms a polyp, or pre-cancerous growth projecting from the wall of the colon. As the polyp grows, a tumor forms. Because the tumor grows slowly, early detection is possible through screening and tests.

Colon cancer is often combined with rectal cancer, which appears in the last several inches of the colon, and can collectively be referred to as “colorectal cancer.”

Risk Factors for Colon Cancer

Some risk factors for colorectal cancer include:

• Over the age of 50
• Personal history of colorectal polyps or colorectal cancer
• Personal history of inflammatory bowel disease
• Family history of colorectal cancer
• Inherited syndromes
• FAP – familial adenomatous polyposis
• HNPCC – hereditary non-polyposis colon cancer also known as Lynch syndrome
• Juvenile polyposis
• Peutz-Jegher
• MYH gene
• Racial and ethnic background – African Americans and Ashkenazi Jews
• Lifestyle factors
• Diet high in red meats and processed meats
• Physical inactivity
• Obesity
• Smoking
• Heavy alcohol use
• Type 2 diabetes

Screening and Prevention of Colon Cancer

Regular screening exams such as colonoscopies can prevent colorectal cancer.  During colonoscopies, any abnormal cells that begin as polyps can be found and removed before they become cancerous. Screening can also result in early detection of colorectal cancer when it is highly curable.

Screening for colorectal cancer should begin at age 50 for those with no identified risk factor other than age. People with a family history or other risk factors should talk to their doctor about starting screening when they are younger.

If you have an early onset of colon polyps, colon cancer, or multiple family members with colon polyps or colon and uterine cancer, you should consider genetic counseling and testing. Genetic counselors can be contacted at Pennsylvania Hospital by calling 215-829-6528 or at the Hospital of the University of Pennsylvania by calling 215-349-8141.

Make an appointment for a colonoscopy at Penn

Read More

Meet Dr. Kosteva, Hematologist-Oncologist at Penn Medicine Valley Forge

We'd like to welcome John A. Kosteva, MD to the Abramson Cancer Center at Penn Medicine Valley Forge. Dr. Kosteva is a part of the Division of Hematology/Oncology and a Clinical Assistant Professor at the University of Pennsylvania School of Medicine.

Dr. Kosteva is board certified in Medical Oncology, Hematology and Internal Medicine. His practice will be in general hematology and oncology with a special emphasis on treating patients with lung cancer.

Prior to joining Penn Medicine, Dr. Kosteva practiced at Crozer Regional Cancer Center and has also been part of the medical staff at a variety of hospitals throughout the Philadelphia and South Jersey region. Dr. Kosteva received his medical degree from Temple University School of Medicine and completed his internship and residency in Internal Medicine at Temple University Hospital. He also completed a fellowship in Hematology/ Oncology at Fox Chase Cancer Center-Temple University Hospital.

The Lung Cancer Program at the Abramson Cancer Center, Penn Medicine Valley Forge

Patients under the care of Penn’s Lung Cancer Program benefit from a multidisciplinary team of specialists and the resources of the Abramson Cancer Center, including internationally recognized specialists in pulmonology, pathology, oncology, radiation therapy and thoracic surgery who help provide the most advanced treatment options. 

Penn Medicine Valley Forge offers patients the very latest in radiation therapy, infusion, lab and pharmacy services--all in one convenient location. Patients also have access to the latest surgical and treatment options, like proton therapy and immunotherapy, at the Abramson Cancer Center.

Learn more about the lung cancer program at the Abramson Cancer Center. 

Read More

Free Yoga Classes At Penn Medicine Valley Forge


Penn Integrative Medicine invites patients and caregivers to try yoga at Penn Medicine Valley Forge as a way to support the mind, body and spirit during and after treatment.

This free class is open to people on all levels, from beginners to advanced practitioners, and is a very gentle and therapeutic yoga practice.

The practice of yoga during cancer treatment can be helpful on many levels--managing side effects of cancer, including nausea and fatigue. Yoga can also promote better sleep and deep relaxation through the simple act of breathing.

Join us in Valley Forge for Yoga

Days: Thursdays
Time: 1 to 2:15 pm
Location: Penn Medicine Valley Forge, Main Lobby Conference Room, 1001 Chesterbrook Boulevard, Berwyn, PA 19312

Participants will be asked to make a donation of their choice to Penn's Yoga Program for each class attended.

About Colleen Schoenhard

Yoga at Valley Forge is taught by Colleen Schoenhard, a nationally certified Yoga/Meditation Instructor with the Yoga Alliance, at the advanced level. Colleen has over twenty-five years of teaching experience. She is an inspiring and knowledgeable teacher whose personal yoga practice and meditation has led her to witness the powerful effects on herself and her students, some of whom suffer from MS, Crohn’s Disease, Gulf War syndrome, cancer, anxiety, depression, divorce, and loss. Yoga classes with Colleen are a nurturing, joyful integration of the physical, mental, and emotional aspects of ourselves.

She studied at the Kripalu Center for Yoga and Health, Omega Institute for Holistic Studies, and the Amrit Yoga Institute with highly qualified, well-known teachers. She currently teaches Classic Hatha Yoga, Kundalini Yoga, Meditation, and Integrative Relaxation (Yoga Nidra) in group classes, private sessions, and workshops in the Philadelphia area. For the last sixteen years, Colleen has taught in Narbeth, PA. She has served on several panels and taught yoga workshops at the Integrative Medicine Conferences at the University of Pennsylvania’s Abramson Cancer Center.

Learn More

For more information, please contact Fern Nibauer-Cohen at 215.662.3919 or Fern.Nibauer-Cohen@uphs.upenn.edu.

Read More

Cancer Is Not Winning - Why I am Riding the Ride to Conquer Cancer

Erica Voll is a social media marketer and blogger who is riding and raising money for the Abramson Cancer Center through the Philadelphia Ride to Conquer Cancer this October. In this blog, she writes about why she's riding to help researchers at Penn conquer cancer. 

Be sure to follow her blog, No Sleep 'til College and Instagram for updates on her training and the ride. 

I am tired of cancer winning.

I know cancer doesn't always "win." There have been amazing breakthroughs in cancer research that has led to better detection, more individualized treatments, and therapies that have led to many remissions.

But with every diagnosis, with every scare and with every scan, cancer interrupts lives. Rich, full lives filled with family, friends, and things still left to do and see all of the sudden seem too short.

In the past 10 years or so, I've met too many young people diagnosed with cancer.

A new mom who thought the lump in her breast was a clogged milk duct she got while breastfeeding.

A young mother of three who found a lump in her chest while in the shower getting ready to take her kids to school.

A father who had to find a way to tell his children he was very ill, and that the outlook was not good.

These are the stories that make me stop in my tracks, look around, and say, "What is going on here??? Why aren't we shouting from the rooftops,'We're tired of being bullied by horrible disease!'"

But when I look around, I see hope. I see the Abramson Cancer Center just over the bridge from my home in New Jersey. I see a place where the best and brightest cancer researchers are making strides in cancer, so that our bodies can fight smarter.

I see a place, where cancer isn't winning. I see a place where the super heroes are researchers, doctors, nurses and caregivers. I see a place where people with cancer aren't giving up.

I am so inspired by the work happening at the Abramson Cancer Center, I wanted to do what I could to support research there - I joined the Ride to Conquer Cancer®.

The Ride to Conquer Cancer is a 2-day, roughly 150-mile bike ride through the countryside (read: hilly) of Philadelphia's suburbs. Every dollar raised through the ride goes to cancer research at the Abramson Cancer Center.

Every dollar.

Won't you join me to help support cancer research?

The Ride to Conquer Cancer®

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque landscape -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two-days and 150+ miles the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to ride side by side with physicians, patients and families--raising serious funds and awareness in the ACC’s fight to cure cancer.

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

Join Today

This event will be remarkable, bringing together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:

• Expert coaching
• Training rides in your area
• Personal web page for fundraising
• Helpful manual
• 2014 ride commemorative item

During the ride, participants will have access to:

• Event-day ride jersey
• Support along the route
• Catered meals
• Entertainment at camp
• Massage and medical care

Read More

Ride to Conquer Cancer - Fundraising Tips

What would happen if we all came together on one day to make an incredible show of support for our loved ones who have been touched by cancer? Let's find out!

Epic Impact Day is today. One day with one very realistic goal: helping every rider in the Philadelphia Ride to Conquer Cancer® get at least one donation.

Get involved here.

Epic Impact Day Chat

To help every rider raise as much as they can for Epic Impact Day, the Philadelphia Ride to Conquer Cancer will host a social media fundraising chat today at 12 pm EST. Join us, to ask all your fundraising questions and be inspired by the efforts of our riders.

Just head to the Ride to Conquer Cancer Facebook page, or use #RTCCPA on Twitter to participate.

Tips for Fundraising

Ask
Think of the people you can ask, who won’t say no: family, friends, co-workers. Get that first donation to start momentum. You can do it! The sooner you get started, the easier it will be to reach beyond $2,500.

Organize
Write down the names of all of the people in your life: family, friends, neighbors, co-workers, family doctor, auto mechanic...don’t leave anyone out. You know a lot of people.

Email
After registering, you’ll receive a simple email template from us. You can use or adjust that language to your liking, then forward it to all of your contacts. They can click on a link in the email, taking them straight to your donation page, where they can give as much as they feel comfortable. Even better, personalize an email with the story about why you are committed to The Ride. Inspire your donors to support you.

Say thanks
Follow up with a phone call to everyone you emailed after a week to secure a donation, if they haven’t already donated online. Let them know their donation is appreciated--their generosity and your kindness helps extend the spirit and hope of this event.

You can also log in to your personal page online, where you will find emails already written, to send as follow ups and thank you's.

Expand Your Giving Circle
Reach people you’ve never met. Have everyone you email forward your donation request to their friends and family.

Use social media like Facebook, Instagram, and Twitter to share your journey and encourage others to support you.

Have family and friends distribute donation forms for you and talk to their contacts about supporting your Ride.

Ask for Corporate Support
Ask your workplace to support your epic journey.

Ask management if your company will contribute to your Ride either through a donation or even donation matching. Don’t be afraid to ask big.

If co-workers express an interest in The Ride, form a corporate team with your company’s support. Everyone will raise more money, and it’s excellent for boosting camaraderie.

Customize Your Personal Page
Your Personal Page is an easy way to share why you’ve made the decision to participate in the Ride to Conquer Cancer.

- Post your photo, tell your story, update your fundraising goal, request donations, and keep track of your fundraising progress.

- Link to your Personal Page in emails and on social media

Riders who customize their pages raise on average 22% more those who don’t

Set Your Goals High
Though the minimum fundraising requirement is $2,500, the average participant raises more than $3,000. How much more can you raise?

Need one more good reason: there are incentives for fundraising, team-building, and other challenges. Remember, you are asking for money to help provide critical cancer research and your impact will be seen and felt.

The Ride to Conquer Cancer®

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer© (RTCC). For most riders, 150* miles over 2 days will be physically challenging. But all will find it to be a weekend that is incredibly rewarding — a chance to truly change the course of cancer research, riding side by side with our physicians, patients, and families, to raise serious funds and awareness in the ACC’s fight to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer. *exact route distance may vary by up to 30 miles

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

Join us

This event will be remarkable and will bring together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:

• Expert coaching
• Training rides in your area
• Personal web page for fundraising
• Helpful manual
• 2014 ride commemorative item

During the ride, participants will have access to:

• Event-day ride jersey
• Support along the route
• Catered meals
• Entertainment at camp
• Massage and medical care

Read More

Men's Health Monday: Prostate Cancer

June is Men's Health Awareness Month. Each Monday in June, we are featuring articles about health issues important for men. Please share these posts with the men in your life.

What is Prostate Cancer?

The prostate gland is part of the male reproductive system located just below the bladder. The prostate is small, about the size of a walnut, producing the fluid found in semen.

Prostate cancer is a disease in which cancerous, or malignant, cells form in the tissues of the prostate. It is the third most common cause of cancer death, in men over 75, though it is rarely found in men younger than 50.

Prostate Cancer Risk and Prevention

While the exact cause of prostate cancer is unknown, men who develop prostate cancer are more likely to have certain risk factors for the disease.

Prostate Cancer Risk Factors

Although the exact cause of prostate cancer is unknown, certain factors can increase the risk of developing prostate cancer:

• Age. Prostate cancer is rare in men under the age of 50. The risk for prostate cancer increases as men get older .
• Family history. Men who have a brother or father with prostate cancer have a higher risk for prostate cancer.
• Race. Prostate cancer occurs more often in African-American men than white men, and it occurs at an earlier age in African American men.

This does not mean men who have one or more of these factors will develop prostate cancer, but they should speak with a physician about their risk.

Prostate Cancer Risk Assessment

Men who have conditions that put them at risk for prostate cancer may benefit from consulting with their physician to determine their risk. If they are at a higher risk for prostate cancer, they may consider getting screened for prostate cancer.

Learn More About Prostate Cancer Treatment at Penn

If you or a loved one has been diagnosed with prostate cancer or an abnormal PSA, you're probably wondering what to do next. Look to Penn's Abramson Cancer Center for the most advanced cancer program in the region - and insights into all your options - including getting a second opinion for your prostate cancer treatment.

Our team will:

• help you understand your PSA levels and guide you towards the next steps you should take;
• ensure you have the most accurate diagnosis using advanced diagnostics;
• offer you the most advanced surgical and radiation treatment options – all in one place;
• answer your questions about the potential side effects of all your options;
• provide an unbiased opinion on your best treatment option.

Call 800-789-PENN (7366) to schedule a consultation with a Penn prostate cancer specialist.

Or, learn more about how we're changing the treatment options and lives of people with all forms of cancer, by finding the cure is within.

Read More

Father’s Day Reflections

Damon with his father, Tom

Damon Kline lost his father to cancer, and is riding to find a cure through the Philadelphia Ride to Conquer Cancer. In this blog, he shares with us a glimpse into the life of his father, Tom, and why he's dedicated to supporting the Abramson Cancer Center. Learn more about his ride here.

My Dad, Tom Kline, was diagnosed with sarcoma in December of 2012. Throughout the year that followed, he underwent 300 hours of chemotherapy, a major surgery to remove his lung, months of radiation treatment, countless procedures, and more hospital stays than I can remember – all at Penn Medicine’s Abramson Cancer Center. Every day brought new obstacles and difficult decisions, which he met head on and without hesitation. Growing up, I always thought my Dad was the strongest, bravest, most fearless man in the world. Years later, as he ferociously battled a disease that weakened him physically, he still proved to be the bravest man I have ever known. He was, and forever will be, my hero.

My Dad lost a hard-fought fight with cancer this past January. He was just 54 years old. He left behind a loving wife, three devoted children, and 2 adoring granddaughters. He passed away just a few weeks before the birth of his third granddaughter and first grandson. He was an incredible family man, and I try every day to be the kind of father to my two children that he was to me, my brother, and my sister. With the support of my family, I will honor my Dad’s legacy by participating in the Ride to Conquer Cancer this October.

Throughout the ups and downs of my Dad’s illness, we never once heard any of his doctors say there was no hope or that there was nothing they could do. New obstacles or unforeseen setbacks were met with resolve, as they tried new methods and different approaches to cure him. The doctors at Penn were intensely dedicated to my Dad’s treatment and care, and their determination helped give our family strength during a time of great uncertainty and fear. We are forever grateful to the incredible doctors at Penn who did everything they possibly could for our Dad until the very end.

I don't know if I will see a cure for cancer in my lifetime, but I am convinced that there are still great advances to be made in the treatment and prevention of cancer. With research, studies and trials from dedicated doctors like those at Penn Medicine, we can continue to diagnose patients earlier than ever before, to expand the available treatment options and to change the prognosis of cancer patients. Since February, we have raised over $11,000 for the Ride to Conquer Cancer and the Abramson Cancer Center. Funding like this will help fuel this much needed research.

Statistics say that one of my Dad's four grandchildren will develop cancer in their lifetime. This is our chance to help them now. After everything my family has been through, we feel a responsibility to do everything we can to help advance the progress of cancer treatment and prevention. I hope you will consider getting involved, either by riding or donating. Together, we can help spare someone else’s family the pain caused by this terrible illness and preserve the memory of fathers like mine, who left this world too soon.

The Ride to Conquer Cancer®

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer® (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque landscape -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two days and 150* miles the RTCC will be a physical challenge—an emotional and inspiring weekend—that will give you a chance to join forces with our physicians, patients, and families to leave everything on the bike course and raise serious funds and awareness in the ACC’s fight to cure cancer.

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

This event will be remarkable and will bring together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

*please note: exact route mileage may vary by up to 30 miles

Read More

Acupuncture Added to Integrative Medicine at Abramson Cancer Center

Integrative medicine and wellness services are offered at the Abramson Cancer Center. Reiki, yoga and acupuncture can supplement traditional cancer treatments - leading to a better quality of life by reducing the side effects of cancer and treatments. Adam Schreiber, acupuncturist for Penn Medicine's Integrative Medicine program, explains the advantages of the procedure for cancer patients.

 

Adam Schreiber

Adam Schreiber is an experienced acupuncturist licensed by the Pennsylvania State Board of Medicine and certified in Oriental Medicine by the National Certification Commission for Acupuncture and Oriental Medicine.

Adam has worked with the director of Penn Medicine's Integrative Medicine and Wellness program, Jun Mao, MD in National Institutes of Health-funded clinical trials of acupuncture, for pain and symptom management in breast cancer, for the last three years.

Well regarded by patients and colleagues as highly professional, compassionate, and skillful, Adam is the first credentialed non-physician acupuncturist to join Penn Medicine.

What is acupuncture? 

Acupuncture originated in China, and has been practiced for more than 2,500 years. It is a technique in which hair-thin needles are inserted through the skin to treat a variety of conditions.

While it is not fully understood, the mechanism through which acupuncture can help pain and symptom distress may involve helping the brain to release neuro-chemicals such as endorphins and helping the brain to better regulate regulate the autonomic nervous system. Through these and other mechanisms of action, acupuncture can help combat the side effects of cancer and aggressive cancer treatment.

How does an acupuncture session work?

During a typical acupuncture session, patients lay comfortably on a cushioned table. An acupuncturist then inserts hair-thin, single-use sterilized needles into the patient's skin in key areas, known to stimulate the body to help heal itself.

Sessions typically lasts between 20 and 40 minutes, depending on the treatment plan for the individual patient.

Schreiber adds, "most patients tolerate the procedure with minimal discomfort - it's not at all like having blood drawn, or receiving a vaccination". Sometimes patients can see results immediately, and sometimes it may take several sessions before any benefit can be realized. Generally speaking, patients will know if acupuncture can help them within four to eight treatments.

How can acupuncture supplement my cancer treatment options and survivorship efforts?

"One of the reasons I like working with cancer patients," says Schreiber, "is because [acupuncture] compliments all the other treatments Penn Medicine is already doing very well. Some of these treatments are really aggressive, and can cause problems outside of their intended effects, like chemotherapy. Acupuncture can help alleviate those side effects - it works with the body's natural ability to heal itself."

Why come to Penn Medicine for acupuncture instead of a neighborhood practice?

Penn’s Integrative Medicine and Wellness program is designed with the cancer patient in mind. It brings acupuncture directly into a conventional cancer therapy setting and treatment is tailored specifically to the patient’s needs. Our doctors and researchers are also hard at work conducting research to better understand how acupuncture intersects with cancer treatment, which will help us to understand how acupuncture can best help each individual patient.

“I think that’s what's nice about it," said Schreiber, "knowing you’re going to an acupuncturist that is comfortable [and experienced] with these types of patients, one who sees them regularly and understands their concerns.”

Scheduling an Appointment
For more information, or to schedule a visit, please call 215-615-5858, extension #4.
Acupuncture services are located on the 4th floor West Pavilion of the Ruth and Raymond Perelman Center for Advanced Medicine.

Read More

The Ride to Conquer Cancer - Your Dollars at Work

Join hundreds of others in the Ride to Conquer Cancer® - a two day, 150* mile bike ride through Pennsylvania's picturesque landscape. Want to know more about what your contribution will bring to the fight against cancer? In this post, we'll explain just how you'll be helping the cancer community.

An opportunity to help cure cancer

Join Penn Medicine’s Abramson Cancer Center (ACC) in the Ride to Conquer Cancer (RTCC)— an unforgettable experience and epic bike ride on October 11 - 12, 2014, through Pennsylvania’s picturesque landscape, heading towards one life-changing destination: curing cancer.

For most riders, covering roughly 150 miles over 2 days will be physically challenging. But all will find it to be a weekend that is incredibly rewarding — a chance to truly change the course of cancer research, riding side by side with our physicians, patients, and families, to raise serious funds and awareness in the ACC’s fight to cure cancer. Clearly, this ride isn't just for serious cyclists, but anyone looking to make a difference.

Putting your dollars to work in the fight against cancer

To join, cyclists are asked to raise a minimum of $2,500 in donations. It’s surprising how quickly the donations add up once you put your heart, creativity, and commitment into securing donations.

Your participation in The Ride to Conquer Cancer will support our team approach to cancer research, education and care; as well as ensuring the sustainability of our core mission:

• Development and support of team-oriented research and care programs specializing in each type of cancer
• Expansion and integration of cancer-related patient services and interdisciplinary clinical programs
• Educational programs for physicians, scientists, students, nurses, and others to stay current on the latest cancer information
• Recruitment and support of new faculty with a commitment to cancer research and care
• Community outreach and education to enhance cancer prevention in our communities
• Investment in the future - as we break through the next frontier of cancer discovery through programs like Penn Medicine's Center for Personalized Diagnostics, Translational Centers of Excellence (TCEs), The Roberts Proton Therapy Center and many others leading the fight.

Join Us

This event will be a remarkable experience, bringing together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. We invite everyone to register today and join us in October, by registering today at www.ridetovictory.org or by calling (844) 777-7433.

*Please note exact route distance may vary by up to 30 miles.

Read More

Beyond Breast Reconstruction: 3-D Areola Tattooing

As a leader in breast reconstruction, Penn Plastic Surgery offers comprehensive services for women at every stage of the breast reconstruction process, from the initial surgery to nipple reconstruction and tattooing.

Breast reconstruction is a surgical procedure, designed to re-create the shape and appearance of a woman’s breast. Most commonly, the procedure is done as part of a mastectomy – surgical removal of the entire breast as treatment for breast cancer.

After breast reconstruction, many women choose to have nipple reconstruction, including nipple tattooing. Nipple tattooing, or micropigmentation, re-pigments the area to make it look more realistic.

Mandy Sauler, micropigmentation

specialist

At Penn Medicine, nipple tattooing is performed by Mandy Sauler, a micropigmentation specialist in plastic surgery. Mandy grew up learning about the art of tattooing at her mother's body art shop, expecting to work alongside her as she perfected her craft.

After working for more than a decade as a tattoo artist, Mandy decided to apply her expertise on patients, focusing on permanent cosmetics and micropigmentation. She specializes in 3D nipple tattoos, along with tattoos for other cosmetic purposes. She is board certified by the American Academy of Micropigmentation and is a member of the Society of Permanent Cosmetics.

Learn more about nipple and areola enhancement or schedule an appointment with Penn Plastic Surgery.

Read More

Men's Health Monday: Testicular Cancer

June is Men’s Health Awareness Month. In this blog, Barbara Zoltick, RN, discusses testicular cancer, who is at risk and how to perform a self-exam to check for the most common cancer for men between the ages of 15 and 35.

Though it can occur in older men, testicular cancer generally occurs in young men, at the time of life when they are completing their education, finding new jobs, and creating families.

Who is at Risk for Testicular Cancer?

The incidence of testicular cancer has been increasing over the past 40 years for reasons which remain unclear. Testicular cancer is more prevalent in white men than in black, Asian, or other nonwhite ethnic groups. Historically, the incidence has been found to be greater in men of any ethnicity with higher socio-economic status and more education, though more recent studies have found this difference has diminished.

The risk factors associated with the development of testicular cancer are not well established. However, cryptorchidism, or an undescended testicle, is currently the most recognized risk factor. Cryptorchidism increases the risk of developing testicular cancer by ten-fold, though only about 5% of testicular cancers can be attributed to this condition. Additional risk factors include prenatal exposure to estrogen; other testicular abnormalities, such as underdeveloped testicles; and genetic disorders that affect sexual development, such as Kleinfelter’s Syndrome.

Fortunately, testicular cancer is one of the most curable cancers. Men diagnosed and treated when the disease is still in an early stage have a 97 to 100 percent chance of being cured. Therefore, early detection is critical.

What Testicular Cancer Looks Like

The most common sign of testicular cancer is a lump, swelling or enlargement of a testicle. This may be accompanied by tenderness, pain or a feeling of heaviness. Unfortunately, after noticing a change in a testicle, some men wait several months before seeking a medical evaluation. The disease is then more advanced upon diagnosis, possibly requiring more intensive treatment and potentially decreasing the chance of a cure. Monthly testicular self-examinations can help, by making a mental note of and becoming more familiar with how testicles normally feel.

It is also important to note that not every change or discomfort indicates cancer — seeking medical evaluation can provide reassurance that cancer is not the cause.

How to Perform a Testicular Self-Exam

• Check for any swelling on the scrotum. You may need to do this in front of a mirror.
• Examine one testicle at a time, using both hands. Put your index and middle fingers under the testicle with thumbs on top. Roll the testicle gently between your fingers. It can be normal for one testicle to be slightly larger than the other.
• You will notice a soft, tube-like area behind the testicles. This is the epididymis, where sperm is stored.
• Any testicular changes, pain, swelling, lump or tender area should be evaluated by a health care professional, preferably a urologist as soon as possible. It may not be cancer, but needs to be evaluated to be sure.

Read More

Ride To Conquer Cancer - Jim's Story, and His Tips for New Riders

As a competitive cyclist in the 70s, Jim Finkel rode alongside some of the best cyclists in the world. He didn’t know it at the time, but his constant challenges to go faster, work harder, go longer distances, and fuel his body with proper nutrition got him in shape for the greatest challenge of his life – cancer.

And, in a way, cycling saved his life.

“Towards the end of 2012 I was having trouble breathing, either on or off the bike,” says the 61-year-old mechanical engineer. “I was unable to clear my nostrils as I rode, and when over-the-counter medications and antibiotics didn’t work, we knew it was time to take the next step toward a proper diagnosis.”

After scopes and scans revealed a tumor in his nasal cavity, Jim began an 18-month journey to treat cancer that involved two surgeries, and radiation therapy. But he barely took a break from his bike.

“When it was warm enough to ride outside, I immediately started to kick up my mileage while not pushing too hard,” says Jim. “Once I’d started radiation therapy, I was back up to doing at least four hours a week of saddle time on a bike.”

“Keeping my weight up during treatment was a challenge, but cycling actually helped. Though my sense of taste was dulled, I was used to getting calories back in to my body. I knew I had to eat and carefully match my calories in to calories burned, so I held weight throughout the process.”

Jim has joined the Abramson Cancer Center’s Ride to Conquer Cancer, a 150-mile ride that benefits cancer research at the Abramson Cancer Center.

“I can’t say enough about the Abramson Cancer Center,” says Jim. “My surgeon Dr. O’Malley, my oncologist, Dr. Chip Staddon at Penn Medicine at Radnor, and Dr. Geoffrey Geiger at both the Valley Forge and the Perelman Center for Advanced Medicine always put me as a person in front of me as a patient. I want my story to give others hope.”

You don’t have to be a competitive cyclist to join the ride, however. In fact, Jim shares these tips for those people riding the event who may not be seasoned cyclists.

1. Get slick tires: Even if you are riding a mountain bike, swapping out the heavy tread for slick, thinner tires will help you maintain speed with less effort.
2. Inflate your tires to their recommended levels: Again, this will be less work to ride.
3. Proper fit: Regardless of the bike you ride, make sure it fits you. Take it to a bike shop and have a professional adjust your bike to you.
4. Drink enough water: Jim loses about three pounds an hour during a ride. Make sure you rehydrate throughout the ride and at rest stops.
5. Helmet: Always wear one!
6. Know when to shift: It will make your riding easier.
7. Get proper attire: Cycling shorts aren’t just nice, but necessary. Gloves can also act as a comfort measure; as well as protection should you fall off your bike.

The Ride to Conquer Cancer©

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer© (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque scenery -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two-days and 150+ miles the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to join forces with our physicians, patients, and families to leave everything on the bike course and raise serious funds and awareness in the ACC’s fight to cure cancer.

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

JOIN TODAY!

This event will be remarkable and will bring together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:

• Expert coaching
• Training rides in your area
• Personal web page for fundraising
• Helpful manual
• 2014 ride commemorative item

During the ride, participants will have access to:

• Event-day ride jersey
• Support along the route
• Catered meals
• Entertainment at camp
• Massage and medical care

Read More

Live Comedy at the Hospital of the University of Pennsylvania with the HEADStrong Foundation

Join the HEADStrong Foundation for a Night of Fun

Join the HEADStrong Foundation for a night of fun on Thursday, June 12 from 5 to 7 pm on Rhoads Conference Rooms 3,6 and 7 at the Hospital of the University of Pennsylvania.

Comedians Joe Conklin, Chris Ruggiero and Michael Baldini will bring the laughs to patients and their families. Refreshments will also be available.

The HEADstrong Foundation for blood cancer is committed to finding a cure for all blood cancers.

The foundation is dedicated to its founder Nicholas Colleluori, who was diagnosed with non-Hodgkin lymphoma in 2005, and passed away in November, 2006.

The foundation strives on Nick’s quote, “Making use of the time you have and don’t stress the little things. Have a smile and enjoy what you can get out of life.”

Read more about the HEADStrong Foundation here.

Read More

Men's Health Monday: Health Screenings for Men

June is Men's Health Awareness Month. In this blog post, we'll explore the top three cancer types affecting men of all ages in the United states, as well as some of the important screenings men should be aware of to help stay one step ahead of cancer. 

Screening for Prostate Cancer

Prostate cancer is the most common cancer found in American men, and sits as the second leading cause of cancer-related death in men. The American Cancer Society estimates that one in seven men will get prostate cancer during his lifetime. 

While over 230,000 new cases of prostate cancer are diagnosed each year in the United States, tests like PSA screenings and digital rectal exams can dramatically increase your chance of survival.The prostate gland produces a protein known as prostate-stimulating antigen, or PSA.

As these levels are known to rise before other symptoms of prostate cancer appear, it is important to seek out a regular exam starting in the mid-twenties.

Learn more in our PSA levels and prostate cancer.

Screening and Self-Exams for Testicular Cancer

Testicular cancer is most common in men between 15 and 35 years of age. The American Cancer Society estimates that in 2014  8,820 men will be diagnosed, with only about 380 men dying as a result.

Fortunately, testicular cancer is one of the most curable cancers. Men diagnosed and treated when the disease is in an early stage have a 97 to 100 percent chance of being cured. Therefore, early detection is critical - and relatively easy to do frequently, and at home.

The most common way to check is to perform a monthly testicular self-exam. Unfortunately, after noticing a change in a testicle, many men wait several months before seeking a medical evaluation. The disease is then more advanced upon diagnosis, possibly requiring more intensive treatment and potentially decreasing the chance of a cure.

Learn more about testicular cancer and how to perform a self-exam. 

Checking for Colorectal Cancer

Colorectal cancer is the third most common cancer type found in both men and women (outside of skin cancers) in the United States, but thanks to awareness around colonoscopy screenings, the death rate from this cancer has dropped in recent years. Typically it affects people over 50 years old, as well as those those with a hereditary history of colorectal cancer.

Colorectal cancer is often beatable when detected and treated in its early stages and can even be prevented altogether when polyps are removed before they develop into cancer. It’s important to know that symptoms of colorectal cancer -  can look like symptoms of other conditions.

Roughly 80 percent of colorectal cancer cases can be prevented with adequate colonoscopy screening - often saving lives. We encourage everyone to begin a dialogue about colorectal cancer screening with their physicians. While no screening test is 100 percent perfect, colonoscopy remains the best method of screening for most individuals.

Request a colonoscopy appointment at Penn Medicine today.

Read More